People: Novo Nordisk A/S (NVO)

NVO on New York Consolidated

43.58USD
17 Dec 2014
Price Change (% chg)

$0.29 (+0.67%)
Prev Close
$43.29
Open
$43.50
Day's High
$43.94
Day's Low
$43.24
Volume
2,415,331
Avg. Vol
1,498,959
52-wk High
$49.10
52-wk Low
$34.81

Search Stocks

Rebien Soerensen, Lars 

Brief Biography

Mr. Lars Rebien Soerensen has served as Chief Executive Officer (CEO) at Novo Nordisk A/S since November 2000. He also served as President of the Company from November 2000 until January 30, 2014. He joined the Company's Enzymes Marketing in 1982. Over the years, he has been stationed in several countries, including the Middle East and the United States. He was appointed Member of Corporate Management in May 1994, and was given responsibility for Health Care within Corporate Management in December 1994. He is Member of the Boards of Directors of Danmarks Nationalbank and Thermo Fisher Scientific Inc., as well as Member of the Bertelsmann AG Supervisory Board in Germany. He received the French award Chevalier de l'Ordre National de la Legion d'Honneur in 2005. Since October 2007, he has been Adjunct Professor at the Faculty of Life Sciences of Koebenhavns Universitet (the University of Copenhagen). He holds a Master of Science degree in Forestry from Koebenhavns Universitet from 1981 and a Bachelor of Science degree in International Economics from Copenhagen Business School from 1983.

Basic Compensation

Total Annual Compensation, DKK Long-Term Incentive Plans, DKK All Other, DKK Fiscal Year Total, DKK
19,000,000 -- 300,000 19,300,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Goran Ando

1,500,000

Kaare Schultz

11,700,000

Lars Rebien Soerensen

19,300,000

Jeppe Christiansen

800,000

Jesper Brandgaard

10,400,000

Lars Fruergaard Joergensen

7,200,000
As Of 30 Dec 2013
Search Stocks